This content is only available within our institutional offering.

23 Apr 2024
FY23 results – pivotal period ahead

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
FY23 results – pivotal period ahead
Trellus Health PLC (TRLS:LON) | 0.6 0 0.0% | Mkt Cap: 0.97m
- Published:
23 Apr 2024 -
Author:
Chris Glasper -
Pages:
3 -
With the signing of a large-scale pilot contract with United Healthcare in February, Trellus is entering a key period in its development. Patient enrolment is underway and both management and the partner are reported to be encouraged by early adoption trends. It is well capitalised, with $12.2m in cash as at the end of Dec-23 and has completed development of an enterprise technology platform capable of being used at scale. The cash runway has been extended to mid-2025, providing management with a window of opportunity to scale the business and provide further real-world evidence of the utility of the Trellus Elevate methodology. We look forward to further updates in due course.